RetaMaps

Oviedo Med Spa

Oviedo Med Spa · 816 Executive Drive · Oviedo, FL 32765

5.0· 304 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

Care described on the practice's website

  • Medically supervised weight loss

About this practice

Oviedo Med Spa is a medical aesthetics practice in Oviedo, Florida, and its website says it serves Winter Springs and Orlando. The site lists injectables, skin rejuvenation, wellness and massage therapy, and says its team includes board-certified physicians, nurse practitioners and aestheticians. The listing also shows weight-loss care. Google shows a 5.0-star rating across 304 reviews dating to 2023, with 83 in the past year, and reviewers most often mention the staff and the team's knowledge, with 6 mentioning results.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 5.0
Google rating · 304 reviews
83
reviews in the past year (avg ★ 5.0)
2
reviews mention GLP-1 medications

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-25. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★5.0 across 304 Google reviews. Of the 100 reviews we analyzed, 99 (99%) are positive (4–5★) and 1 (1%) are negative (1–2★).

What patients like

  • Friendly, helpful staff38 reviews
  • Knowledgeable, professional providers21 reviews
  • Clean, comfortable office8 reviews
  • Weight-loss results6 reviews

Common complaints

Very few complaints — only 1 negative review, with no recurring theme.

5★
99
4★
0
3★
0
2★
0
1★
1

Most recent Google reviews

Steffani I.★★★★★2026-09-25

Highly recommend this med spa. I see Jo, the aesthetician monthly. She is very knowledgeable with skin and always uplifting and positive.

Ashleigh J.★★★★★2026-09-25

Exceptional services and beautiful space 💕

Fiona-Marie J.★★★★★2026-09-24

THIS IS ONE OF THE BEST SPA'S IVE EVER VISITED. THE STADF IS SUPER FRIENDLY AND INCREDIBLY KNOWLEDGEABLE. THEY MAKE YOU FEEL WELCOMED AND COMFORTABLE THE SECOND YOU ENTER. DEFINITELY WORTH THE VISIT!

Florence Z.★★★★★2026-09-24

I recently became a member, and I’m super happy I did! Their med spa is absolutely beautiful, and their entire staff is kind and makes you feel welcomed. I’ve seen Devin and Jo for facials, and they are both the best! They’ve helped my skin a lot but have never been pushy, which I appreciate. I’ve also seen Shayne for sculptra, and she made the entire experience extremely positive! I usually bruise; and I didn’t bruise at all with her. Oviedo Med Spa is a wonderful addition to Oviedo, I’m happy I found them!

Pippi B.★★★★★2026-09-24

Such an amazing med spa with the friendliest staff’

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Nearby providers in Oviedo

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs